Cure Alzheimer's Fund Cure Alzheimer's Fund

Meike Vernooij, M.D., Ph.D.,

Neuroradiologist, Head & Neck Radiologist; Professor of Population Imaging at the Departments of Radiology & Nuclear Medicine and Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Meike Vernooij, M.D., Ph.D., is a Neuroradiologist, Head & Neck Radiologist, and Professor of Population Imaging at the Departments of Radiology & Nuclear Medicine and Epidemiology at Erasmus University Medical Center, Rotterdam, The Netherlands.

Dr. Vernooij completed her MSc in Epidemiology from the Netherlands Institute of Health Sciences, and her M.D. and Ph.D. (both with honors) from Erasmus University, Rotterdam, The Netherlands. Additionally, she has completed a residency in Radiology at Erasmus MC University Medical Center and a clinical fellowship in Neuroradiology and Head & Neck Radiology from the same medical center.

Since 2005, Dr. Vernooij has been studying the use of MRI in the investigation of age-related brain changes, specifically those which may be used as preclinical markers for cerebrovascular and neurodegenerative diseases. Within the population-based setting of The Rotterdam Study, she focuses on the determinants and consequences of advanced imaging markers such as cerebral microbleeds, cerebral blood flow, and microstructural white matter integrity; with a particular focus on markers of cerebral small vessel disease. Her work has been recognized with the European Prize for Neuroradiology (Lucien Appel Prize 2014), the Stroke Innovation Award by the Journal Stroke, and the Lourens Penning Prize of the Dutch Society of Radiology. Dr. Vernooij has authored over 350 peer-reviewed publications in the field of Population Neuroimaging and is currently supervising seven Ph.D. students and three postdoctoral researchers.

Related Research:

Disentangling the Role of Intracranial Arteriosclerosis in Alzheimer’s Disease Daniel Bos Frank J. Wolters Geert Jan Biessels Julia Neitzel Meike Vernooij 2022-02-10

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Disentangling the Role of Intracranial Arteriosclerosis in Alzheimer’s Disease 2021, 2023

$339,258.55

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Claus, J. J., Vom Hofe, I., van Ijlzinga Veenstra, A., Licher, S., Seelaar, H., de Jong, F. J., Neitzel, J., Vernooij, M. W., Ikram, M. A., & Wolters, F. J. Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer’s disease to individuals with mild cognitive impairment or early Alzheimer’s disease in the general population, European Journal of Epidemiology, March 23, 2025, Read More

Claus, J. J., Rosbergen, M. T., Roshchupkin, G. V., Ikram, M. A., Vernooij, M. W., & Wolters, F. J. Validation of a novel neuroimaging signature for dementia and clinical Alzheimer’s disease in the population-based Rotterdam study, Journal of Alzheimer's Disease, February 16, 2025, Read More

Streiber, A. M., Neitzel, J., Nguyen Ho, P. T., Vernooij, M. W., & Bos, D. Intracranial arteriosclerosis is not associated with cerebral amyloid deposition, Alzheimer's & Dementia, October 1, 2024r, Read More

van den Beukel, T. C., Wolters, F. J., Siebert, U., Spiering, W., Ikram, M. A., Vernooij, M. W., de Jong, P. A., & Bos, D. Intracranial arteriosclerosis and the risk of dementia: A population-based cohort study, Alzheimer's & Dementia, October 9, 2023, Read More

Back to Our Researchers